Loading...
NPI 1669762795 · Peoria, IL · Hematology & Oncology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Venkata Damarla is a hematology & oncology physician provider located in Peoria, Illinois. This profile covers 81 Medicare and 13 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Venkata Damarla |
| Address | 8940 N Wood Sage Rd |
| City | Peoria |
| State | IL |
| ZIP | 61615 |
| Taxonomy | Hematology & Oncology Physician |
| NPI Enumerated | April 11, 2011 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $1.7M |
| Medicaid | $106.4K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
81 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 10,440 | $40 | $396.7K |
| J9271 | Injection, pembrolizumab, 1 mg | 8,600 | $40 | $369.8K |
| J9173 | Injection, durvalumab, 10 mg | 4,050 | $60 | $234.9K |
| J0897 | Injection, denosumab, 1 mg | 8,880 | $20 | $168.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 600 | $90 | $56.1K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 660 | $80 | $55.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 430 | $90 | $39.2K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 410 | $100 | $39.2K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,530 | $30 | $38.3K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 14,650 | $1 | $29.3K |
Showing 1–10 of 81
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 81 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
81 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| J9271 | 66 | 110 | 11,600 | $40 | $564.2K |
| J9173 | 3 | 10 | 4,050 | $60 | $346.8K |
| J9144 | 14 | 50 | 7,740 | $40 | $341.8K |
| J0897 | 56 | 410 | 2,520 | $20 | $90.8K |
| Q5119 | 27 | 40 | 1,970 | $20 | $50.6K |
| Q5122 | 15 | 30 | 410 | $90 | $44.1K |
| J0881 | 28 | 70 | 11,600 | $1 | $38.2K |
| J2506 | 9 | 70 | 320 | $80 | $32.9K |
| 78815 | 309 | 370 | 50 | $360 | $30.9K |
| J1439 | 45 | 80 | 25,500 | $1 | $30K |
Showing 1–10 of 81
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
13 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 1,230 | $40 | $45.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 670 | $40 | $29.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 200 | $60 | $12.6K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 170 | $30 | $5.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 330 | $10 | $3.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 510 | $10 | $3.1K |
| J1750 | Injection, iron dextran, 50 mg | 20 | $120 | $2.8K |
| J1756 | Injection, iron sucrose, 1 mg | 50 | $40 | $1.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 10 | $60 | $780 |
| 85027 | The lab analyst performs a blood count on the red and white blood cells and platelets also known as thrombocytes. He also determines the hemoglobin, typically by spectrophotometry, and the… | 100 | $10 | $580 |
Showing 1–10 of 13
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
13 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 446 | 740 | 960 | $10 | $75.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 4,863 | 14,680 | 300 | $50 | $48.7K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 444 | 830 | 700 | $1 | $47.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 73 | 150 | 170 | $50 | $39.9K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 36 | 80 | 150 | $40 | $29.3K |
| 85027 | The lab analyst performs a blood count on the red and white blood cells and platelets also known as thrombocytes. He also determines the hemoglobin, typically by spectrophotometry, and the… | 277 | 340 | 1,190 | $1 | $23.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 2,444 | 2,800 | 60 | $80 | $17.7K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 33 | 40 | 280 | $30 | $17.4K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 93 | 2,320 | 70 | $50 | $13.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 258 | 330 | 30 | $120 | $12.9K |
Showing 1–10 of 13
Other providers in the same ZIP code as Venkata Damarla, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| J A K Enterprises Inc | IL | Eyewear Supplier | $0 | $13.9M |
| Saint Francis Medical Center | IL | Home Health Agency | $0 | $11.3M |
| Luke Xie | IL | Family Medicine Physician | $41.9K | $2.9M |
| Center For Health Ambulatory Surgery Center, LLC | IL | Ambulatory Surgical Clinic/Center | $2.8M | $0 |
| Jijun Liu | IL | Hematology & Oncology Physician | $2.4M | $326.8K |
| Michael Veeder | IL | Hematology & Oncology Physician | $2.4M | $153.7K |
| Paul Fishkin | IL | Hematology & Oncology Physician | $2.1M | $240.1K |
| Gregory Gerstner | IL | Hematology & Oncology Physician | $1.9M | $166.7K |
| Cristen Banks | IL | Nurse Practitioner | $2M | $17.5K |
| Madhuri Bajaj | IL | Hematology & Oncology Physician | $1.8M | $153.1K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.